DARA : Summary for DARA Biosciences, Inc. - Yahoo Finance

U.S. Markets closed

DARA Biosciences, Inc. (DARA)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.880.00 (0.00%)
At close: 4:59PM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.88
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. VolumeN/A
Market Cap
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • DARA BioSciences, Inc. Earnings Q3, 2015
    Capital Cubelast year

    DARA BioSciences, Inc. Earnings Q3, 2015

    Click here to see latest analysisDARA BioSciences, Inc. reports financial results for the quarter ended September 30, 2015.We analyze the earnings along side the following peers of DARA BioSciences, Inc. – Puma Biotechnology, Inc., Cyclacel Pharmaceuticals, Inc., Oculus Innovative Sciences, Inc., Cardinal Health, Inc., AMAG Pharmaceuticals, Inc., OncoMed Pharmaceuticals, Inc., Array BioPharma Inc. and AmerisourceBergen […] (Read more...) The post DARA BioSciences, Inc. Earnings Q3, 2015 appeared first on CapitalCube.

  • Marketwiredlast year

    DARA BioSciences Announces Stockholder Approval of Merger With Midatech

    DARA BioSciences, Inc. , an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their ...

  • Marketwiredlast year

    DARA BioSciences Announces Third Quarter 2015 Results

    DARA BioSciences, Inc. , an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their ...